144 related articles for article (PubMed ID: 34993966)
1. Neonatal inflammatory skin and bowel disease type 1 caused by a complex genetic defect and responsive to combined anti-tumour necrosis factor-α and interleukin-12/23 blockade.
Samuelov L; Sarig O; Malovitski K; Bergson S; Meijers O; Shouval DS; Sprecher E
Br J Dermatol; 2022 Jun; 186(6):1026-1029. PubMed ID: 34993966
[TBL] [Abstract][Full Text] [Related]
2. Functionally confirmed compound heterozygous ADAM17 missense loss-of-function variants cause neonatal inflammatory skin and bowel disease 1.
Imoto I; Saito M; Suga K; Kohmoto T; Otsu M; Horiuchi K; Nakayama H; Higashiyama S; Sugimoto M; Sasaki A; Homma Y; Shono M; Nakagawa R; Hayabuchi Y; Tange S; Kagami S; Masuda K
Sci Rep; 2021 May; 11(1):9552. PubMed ID: 33953303
[TBL] [Abstract][Full Text] [Related]
3. Novel DSP Spectrin 6 Region Variant Causes Neonatal Erythroderma, Failure to Thrive, Severe Herpes Simplex Infections and Brain Lesions.
Vakkilainen S; Puhakka L; Klemetti P; Heiskanen K; Seppänen M; Muona M; Posseme C; Duffy D; Väisänen T; Elomaa O; Palomäki M; Saxén H; Ranki A; Hannula-Jouppi K
Acta Derm Venereol; 2019 Jul; 99(9):789-796. PubMed ID: 31037311
[TBL] [Abstract][Full Text] [Related]
4. ADAM17 orchestrates Interleukin-6, TNFα and EGF-R signaling in inflammation and cancer.
Schumacher N; Rose-John S
Biochim Biophys Acta Mol Cell Res; 2022 Jan; 1869(1):119141. PubMed ID: 34610348
[TBL] [Abstract][Full Text] [Related]
5. Annexin A2 regulates a disintegrin and metalloproteinase 17-mediated ectodomain shedding of pro-tumor necrosis factor-α in monocytes and colon epithelial cells.
Tsukamoto H; Tanida S; Ozeki K; Ebi M; Mizoshita T; Shimura T; Mori Y; Kataoka H; Kamiya T; Fukuda S; Higashiyama S; Joh T
Inflamm Bowel Dis; 2013 Jun; 19(7):1365-73. PubMed ID: 23702712
[TBL] [Abstract][Full Text] [Related]
6. Critical role of the disintegrin metalloprotease ADAM17 for intestinal inflammation and regeneration in mice.
Chalaris A; Adam N; Sina C; Rosenstiel P; Lehmann-Koch J; Schirmacher P; Hartmann D; Cichy J; Gavrilova O; Schreiber S; Jostock T; Matthews V; Häsler R; Becker C; Neurath MF; Reiss K; Saftig P; Scheller J; Rose-John S
J Exp Med; 2010 Aug; 207(8):1617-24. PubMed ID: 20603312
[TBL] [Abstract][Full Text] [Related]
7. Loss of ADAM17 is associated with severe multiorgan dysfunction.
Bandsma RH; van Goor H; Yourshaw M; Horlings RK; Jonkman MF; Schölvinck EH; Karrenbeld A; Scheenstra R; Kömhoff M; Rump P; Koopman-Keemink Y; Nelson SF; Escher JC; Cutz E; Martín MG
Hum Pathol; 2015 Jun; 46(6):923-8. PubMed ID: 25804906
[TBL] [Abstract][Full Text] [Related]
8. Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment.
Tillack C; Ehmann LM; Friedrich M; Laubender RP; Papay P; Vogelsang H; Stallhofer J; Beigel F; Bedynek A; Wetzke M; Maier H; Koburger M; Wagner J; Glas J; Diegelmann J; Koglin S; Dombrowski Y; Schauber J; Wollenberg A; Brand S
Gut; 2014 Apr; 63(4):567-77. PubMed ID: 23468464
[TBL] [Abstract][Full Text] [Related]
9. Ustekinumab for skin reactions associated with anti-tumor necrosis factor-α agents in patients with inflammatory bowel diseases: A single-center retrospective study.
Ezzedine K; Visseaux L; Cadiot G; Brixi H; Bernard P; Reguiai Z
J Dermatol; 2019 Apr; 46(4):322-327. PubMed ID: 30816581
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Efficacy of Interleukin 12/Interleukin 23 Blockade in Generalized Pustular Psoriasis Regardless of IL36RN Mutation Status.
Arakawa A; Ruzicka T; Prinz JC
JAMA Dermatol; 2016 Jul; 152(7):825-8. PubMed ID: 27096382
[TBL] [Abstract][Full Text] [Related]
11. The membrane-proximal domain of A Disintegrin and Metalloprotease 17 (ADAM17) is responsible for recognition of the interleukin-6 receptor and interleukin-1 receptor II.
Lorenzen I; Lokau J; Düsterhöft S; Trad A; Garbers C; Scheller J; Rose-John S; Grötzinger J
FEBS Lett; 2012 Apr; 586(8):1093-100. PubMed ID: 22575642
[TBL] [Abstract][Full Text] [Related]
12. Predictors of Primary Response to Biologic Treatment [Anti-TNF, Vedolizumab, and Ustekinumab] in Patients With Inflammatory Bowel Disease: From Basic Science to Clinical Practice.
Gisbert JP; Chaparro M
J Crohns Colitis; 2020 Jun; 14(5):694-709. PubMed ID: 31777929
[TBL] [Abstract][Full Text] [Related]
13. Epithelial Cell-Derived a Disintegrin and Metalloproteinase-17 Confers Resistance to Colonic Inflammation Through EGFR Activation.
Shimoda M; Horiuchi K; Sasaki A; Tsukamoto T; Okabayashi K; Hasegawa H; Kitagawa Y; Okada Y
EBioMedicine; 2016 Mar; 5():114-24. PubMed ID: 27077118
[TBL] [Abstract][Full Text] [Related]
14. Tumour necrosis factor-alpha stimulates expression of TNF-alpha converting enzyme in endothelial cells.
Bzowska M; Jura N; Lassak A; Black RA; Bereta J
Eur J Biochem; 2004 Jul; 271(13):2808-20. PubMed ID: 15206946
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory skin and bowel disease linked to ADAM17 deletion.
Blaydon DC; Biancheri P; Di WL; Plagnol V; Cabral RM; Brooke MA; van Heel DA; Ruschendorf F; Toynbee M; Walne A; O'Toole EA; Martin JE; Lindley K; Vulliamy T; Abrams DJ; MacDonald TT; Harper JI; Kelsell DP
N Engl J Med; 2011 Oct; 365(16):1502-8. PubMed ID: 22010916
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the cDNA and gene for mouse tumour necrosis factor alpha converting enzyme (TACE/ADAM17) and its location to mouse chromosome 12 and human chromosome 2p25.
Cerretti DP; Poindexter K; Castner BJ; Means G; Copeland NG; Gilbert DJ; Jenkins NA; Black RA; Nelson N
Cytokine; 1999 Aug; 11(8):541-51. PubMed ID: 10433800
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms of the tumor necrosis factor-alpha (TNF) and the TNF-alpha converting enzyme (TACE/ADAM17) genes in relation to cardiovascular mortality: the AtheroGene study.
Morange PE; Tregouet DA; Godefroy T; Saut N; Bickel C; Rupprecht HJ; Lackner K; Barbaux S; Poirier O; Peiretti F; Nalbone G; Juhan-Vague I; Blankenberg S; Tiret L
J Mol Med (Berl); 2008 Oct; 86(10):1153-61. PubMed ID: 18600307
[TBL] [Abstract][Full Text] [Related]
18. [Intralesional and anatomopathologic features of psoriatic erythroderma].
Samoud El Kissi S; Cherif Ben Hmida F; Ben Osman Dahri A; Boubacker MS; Hechmi-Louzir M
Tunis Med; 2007 Jul; 85(7):573-5. PubMed ID: 18064989
[TBL] [Abstract][Full Text] [Related]
19. The spectrum of manifestations in desmoplakin gene (DSP) spectrin repeat 6 domain mutations: Immunophenotyping and response to ustekinumab.
Paller AS; Czarnowicki T; Renert-Yuval Y; Holland K; Huynh T; Sadlier M; McAleer MA; Tran G; Geddes GC; Irvine AD; Guttman-Yassky E
J Am Acad Dermatol; 2018 Mar; 78(3):498-505.e2. PubMed ID: 29066275
[TBL] [Abstract][Full Text] [Related]
20. A disintegrin and metalloprotease (ADAM) 10 and ADAM17 are major sheddases of T cell immunoglobulin and mucin domain 3 (Tim-3).
Möller-Hackbarth K; Dewitz C; Schweigert O; Trad A; Garbers C; Rose-John S; Scheller J
J Biol Chem; 2013 Nov; 288(48):34529-44. PubMed ID: 24121505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
